glp receptor 1 agonists GLP-1 for individualized treatment of type 2 diabetes mellitus GLP-1R and Diabetes

However, GLP-1s accounted for over 8% of all Medicaid prescription drug spending before rebates in 2024 (up from 1% in 2019)

Pill forms of the drugs simplify the entire process from manufacturing to administration, says Sean Wharton, an obesity medicine clinician and researcher at the Wharton Medical Clinic in Ontario

SGLT2 inhibitor users had the highest rates of hypertension and cardiovascular disease, whereas women prescribed GLP-1R agonists were more likely to be obese or suffer from polycystic ovarian syndrome (PCOS)

The combination of metabolic improvements positions GLP-1 receptor agonists as potentially valuable therapeutic agents for MASLD and NASH

Philip Pape: 2:21 I want to give a special shout out to Michael Kay, one of our longtime listeners

Higher mean age and baseline SBP, greater use of anti-hypertensive medications, longer T2D duration, and reduction in insulin daily dose might have contributed to explain the difference observed in the impact of weight loss on SBP reduction in these trials, although direct GLP-1R- and GIP-R-mediated effects could also be considered [77]